This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

SYNTAX II and SYNTAX III Trials: What is the Take Home Message for Surgeons?

Wednesday, September 5, 2018

Submitted by


Source Name: Annals of Cardiothoracic Surgery


Rodrigo Modolo, Carlos Collet, Yoshinobu Onuma, Patrick W. Serruys

Modolo and colleagues provide detailed analysis and straightforward description of the SYNTAX II and SYNTAX III trials, including the impact for surgeons in contemporary practice. The article addresses both sides of the percutaneous coronary intervention (PCI) versus CABG debate with evidence from the SYNTAX II and III trials, examining specifically the outcomes of state-of-the-art PCI and CABG and comparison of heart team findings and decision making using computed tomographic angiography (including FFRCT) or conventional angiography.

Add comment

Log in or register to post comments